This third of five exclusive episodes explores how clinicians can navigate newly approved MASH therapies -- resmetirom (Rezdiffra) and semaglutide (Wegovy) -- and how to tailor treatment choices based ...

The LDL-C reductions seen with enlicitide in both studies are in the same ballpark as those seen with injectable ...

Esperion faces pressure from emerging oral PCSK9i and CETP inhibitors, which offer superior LDL-c lowering. See why I rate ...

New drugs that dramatically lower cholesterol and treat hyperlipidemia are preparing to enter the market one after another.

A statin isn’t the only answer anymore to lowering cholesterol. The lipid-reducing medicines, among the most widely prescribed drugs in the U.S., have been a mainstay of heart-disease prevention and ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

Used to treat severely low blood sugar, glucagon can be a lifesaving medication for people with diabetes. Here’s how it works and when and how to use it.

An oral agent is needed because some patients don’t like injectables, and some doctors don’t prescribe them, experts say.

The cholesterol-lowering drug is part of a suite of medicines that also includes MariTide and that Amgen Chief Medical ...

Phase 3 trial data found that people who took the investigational drug enlicitide with their routine cholesterol-lowering ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...